• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Pharmacyclics Inc

+ Add to Watchlist


95.450 EUR 2.050 2.10%

As of 02:16:00 ET on 09/22/2014.

Snapshot for Pharmacyclics Inc (PY2)

Open: 94.173 Day's Range: 94.173 - 95.450 Volume: 10
Previous Close: 97.500 52wk Range: 61.000 - 111.830 1-Yr Rtn: +4.69%

Stock Chart for PY2

No chart data available.
  • PY2:GR 95.450
  • 1D
  • 1M
  • 1Y
Interactive PY2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PY2

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 173.2510
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.7240
Est. PEG Ratio -
Market Cap (M EUR) 7,338.82
Shares Outstanding (M) 75.27
30 Day Average Volume 69
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PY2

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PY2

Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs.

Robert W Duggan "Bob"Chairman/CEOManmeet SoniChief Financial Officer
Mahkam Zanganeh "Maky"Chief Operating OfficerShawn Cline TomaselloChief Commercial Officer
More Company Profile & Key Executives for PY2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil